Extremely high prevalence of multidrug resistant tuberculosis in Murmansk, Russia: A population-based study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 9, 2011, Pages 1119-1126

  Makinen J ^a   Marjamaki M ^a   Haanpera Heikkinen M ^a   Marttila, H ^a   Endourova, L B ^b   Presnova, S E ^b   Mathys, V ^c   Bifani, P ^c   Ruohonen, R ^d   Viljanen, M K ^e   Soini, H ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b Murmansk Regional TB Dispensary   (Russian Federation)

^c SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^d Finnish Lung Health Association   (Finland)

^e UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM IDENTIFICATION; CODON; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HUMAN; KATG GENE; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RPOB GENE; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTITUBERCULAR AGENTS; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; MYCOBACTERIUM TUBERCULOSIS; POLYMORPHISM, GENETIC; PREVALENCE; RUSSIA; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80054756049     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1200-7     Document Type: Article

References (41)

1. WHO (2009) WHO REPORT 2009: Global Tuberculosis Control Epidemiology, Strategy, Financing. World Health Organization
2. Espinal MA (2003) The global situation of MDR-TB. Tuberculosis (Edinb) 83(1-3):44-51 (Pubitemid 36686747)
3. Aziz MA, Wright A, Laszlo A, De Muynck A, Portaels F, Van Deun A, Wells C, Nunn P, Blanc L, Raviglione M (2006) Epidemiology of antituberculosis drug resistance (the Global Project on Anti-tuberculosis Drug Resistance Surveillance): An updated analysis. Lancet 368(9553):2142-2154 (Pubitemid 44914009)
4. Centers for Disease Control and Prevention (2006) Emergence of Mycobacterium tuberculosis with extensive resistance to secondline drugs-worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 55(11):301-305
5. Bifani PJ, Mathema B, Kurepina NE, Kreiswirth BN (2002) Global dissemination of the Mycobacterium tuberculosis WBeijing family strains. Trends Microbiol 10(1):45-52 (Pubitemid 34075264)
6. Glynn JR,Whiteley J, Bifani PJ, Kremer K, van Soolingen D (2002) Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: A systematic review. Emerg Infect Dis 8(8):843-849
7. Lan NT, Lien HT, le Tung B, Borgdorff MW, Kremer K, van Soolingen D (2003) Mycobacterium tuberculosis Beijing genotype and risk for treatment failure and relapse, Vietnam. Emerg Infect Dis 9(12):1633-1635 (Pubitemid 37505466)
8. Brudey K, Driscoll JR, Rigouts L, Prodinger WM, Gori A, Al-Hajoj SA, Allix C, Aristimuno L, Arora J, Baumanis V, Binder L, Cafrune P, Cataldi A, Cheong S, Diel R, Ellermeier C, Evans JT, Fauville-Dufaux M, Ferdinand S, Garcia de Viedma D, Garzelli C, Gazzola L, Gomes HM, Guttierez MC, Hawkey PM, van Helden PD, Kadival GV, Kreiswirth BN, Kremer K, Kubin M, Kulkarni SP, Liens B, Lillebaek T, Ho ML, Martin C, Martin C, Mokrousov I, Narvskaia O, Ngeow YF, Naumann L, Niemann S, Parwati I, Rahim Z, Rasolofo-Razanamparany V, Rasolonavalona T, Rossetti ML, Rusch-Gerdes S, Sajduda A, Samper S, Shemyakin IG, Singh UB, Somoskovi A, Skuce RA, van Soolingen D, Streicher EM, Suffys PN, Tortoli E, Tracevska T, Vincent V, Victor TC, Warren RM, Yap SF, Zaman K, Portaels F, Rastogi N, Sola C (2006) Mycobacterium tuberculosis complex genetic diversity: Mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6:23
9. Madaras T, Danilovits M, Mariandyshev A (2002) Murmansk-Finland tuberculosis project Phase II Evaluation 1997-2001. Project No F/122703
10. Madaras T, Danilovits M (2005) Murmansk-Finland tuberculosis project Phase II Evaluation 2002-2004. Project No F/122703
11. Aziz MA (ed) (2003) Guidelines for surveillance of drug resistance in tuberculosis, 2nd edn. WHO/CDS/TB/2003/320. WHO Geneva
12. Canetti GFW, Khomenko A, Mahler N, Menon NK, Mitchison DA, Rist N, Smeley NA (1969) Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull WHO 41:21-43
13. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J (1997) Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 35(4):907-914 (Pubitemid 27146535)
14. Marttila HJ, Soini H, Vyshnevskiy BI, Otten TF, Vasilyef AV, Huovinen P, Viljanen MK (1998) Rapid detection of rifampin-resistant Mycobacterium tuberculosis by sequencing and line probe assay. Scand J Infect Dis 30(2):129-132 (Pubitemid 28389068)
15. Marttila HJ, Soini H, Huovinen P, Viljanen MK (1996) katG mutations in isoniazid-resistant Mycobacterium tuberculosis isolates recovered from Finnish patients. Antimicrob Agents Chemother 40(9):2187-2189 (Pubitemid 26296270)
16. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, Moghazeh SL, Eisner W, Daniel TM, Kaplan MH, Crawford JT, Musser JM, Kreiswirth BN (1996) Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275(6):452-457 (Pubitemid 26065618)
17. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, Musser JM (1997) Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex indicates evolutionarily recent global dissemination. Proc Natl Acad Sci USA 94(18):9869-9874 (Pubitemid 27408157)
18. WHO (2007) Global tuberculosis control: Surveillance, planning, financing (WHO/HTM/TB/2007.376)
19. Viljanen MK, Vyshnevskiy BI, Otten TF, Vyshnevskaya E, Marjamäki M, Soini H, Laippala PJ, Vasilyef AV (1998) Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994. Eur J Clin Microbiol Infect Dis 17(3):177-183 (Pubitemid 28306265)
20. WHO (2008) Anti-tuberculosis drug resistance in the world. Report No. 4
21. WHO (2006) Guidelines for the programmatic management of drug-resistant tuberculosis. (WHO/HTM/TB 2006.361)
22. Dubiley S, Mayorova A, Ignatova A, Kirillov E, Stepanshina V, Kolesnikov A, Shemyakin I (2005) New PCR-based assay for detection of common mutations associated with rifampin and isoniazid resistance in Mycobacterium tuberculosis. Clin Chem 51(2):447-450 (Pubitemid 40175817)
23. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA (2002) Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 40(6):1930-1937 (Pubitemid 34596365)
24. Baranov AA, Mariandyshev AO, Mannsåker T, Dahle UR, Bjune GA (2009) Molecular epidemiology and drug resistance of widespread genotypes of Mycobacterium tuberculosis in northwestern Russia. Int J Tuberc Lung Dis 13:1288-1293
25. Ruddy M, Balabanova Y, Graham C, Fedorin I, Malomanova N, Elisarova E, Kuznetznov S, Gusarova G, Zakharova S, Melentyev A, Krukova E, Golishevskaya V, Erokhin V, Dorozhkova I, Drobniewski F (2005) Rates of drug resistance and risk factor analysis in civilian and prison patients with tuberculosis in Samara Region, Russia. Thorax 60(2):130-135 (Pubitemid 40222895)
26. Mokrousov I, Filliol I, Legrand E, Sola C, Otten T, Vyshnevskaya E, Limeschenko E, Vyshnevskiy B, Narvskaya O, Rastogi N (2002) Molecular characterization of multiple-drug-resistant Mycobacterium tuberculosis isolates from northwestern Russia and analysis of rifampin resistance using RNA/RNA mismatch analysis as compared to the line probe assay and sequencing of the rpoB gene. Res Microbiol 153(4):213-219 (Pubitemid 34327894)
27. Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I (2005) Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293(22):2726-2731 (Pubitemid 40965084)
28. Van Soolingen D (2001) Molecular epidemiology of tuberculosis and other mycobacterial infections: Main methodologies and achievements. J Intern Med 249(1):1-26 (Pubitemid 32147089)
29. Ködmön C, Niemann S, Lukács J, Sör E, Dávid S, Somoskövi A (2006) Molecular epidemiology of drug-resistant tuberculosis in Hungary. J Clin Microbiol 44(11):4258-4261 (Pubitemid 44737287)
30. Kruuner A, Hoffner SE, Sillastu H, Danilovits M, Levina K, Svenson SB, Ghebremichael S, Koivula T, Kallenius G (2001) Spread of drug-resistant pulmonary tuberculosis in Estonia. J Clin Microbiol 39(9):3339-3345 (Pubitemid 32830336)
31. Nikolayevsky V, Brown T, Balabanova Y, Ruddy M, Fedorin I, Drobniewski F (2004) Detection of mutations associated with isoniazid and rifampin resistance in Mycobacterium tuberculosis isolates from Samara Region, Russian Federation. J Clin Microbiol 42(10):4498-4502 (Pubitemid 39362362)
32. Marttila HJ, Soini H, Eerola E, Vyshnevskaya E, Vyshnevskiy BI, Otten TF, Vasilyef AV, Viljanen MK (1998) A Ser315Thr substitution in KatG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob Agents Chemother 42(9):2443-2445 (Pubitemid 28420396)
33. Ignatova A, Dubiley S, Stepanshina V, Shemyakin I (2006) Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol 55(Pt 10):1413-1418 (Pubitemid 44651669)
34. Ramaswamy S, Musser JM (1998) Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79:3-29 (Pubitemid 29050434)
35. Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, Douglas JT (2002) rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol 40 (3):1091-1094 (Pubitemid 34208678)
36. Lipin MY, Stepanshina VN, Shemyakin IG, Shinnick TM (2007) Association of specific mutations in katG, rpoB, rpsL and rrs genes with spoligotypes of multidrug-resistant Mycobacterium tuberculosis isolates in Russia. Clin Microbiol Infect 13(6):620-626 (Pubitemid 46730669)
37. Hillemann D, Kubica T, Agzamova R, Venera B, Rusch-Gerdes S, Niemann S (2005) Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int J Tuberc Lung Dis 9(10):1161-1167 (Pubitemid 41433807)
38. Shemyakin IG, Stepanshina VN, Ivanov IY, Lipin MY, Anisimova VA, Onasenko AG, Korobova OV, Shinnick TM (2004) Characterization of drug-resistant isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 8(10):1194-1203 (Pubitemid 39371832)
39. Aktas E, Durmaz R, Yang D, Yang Z (2005) Molecular characterization of isoniazid and rifampin resistance of Mycobacterium tuberculosis clinical isolates from Malatya, Turkey. Microb Drug Resist 11(2):94-99 (Pubitemid 40705816)
40. Titov LP, Zakerbostanabad S, Slizen V, Surkova L, Taghikhani M, Bahrmand A (2006) Molecular characterization of rpoB gene mutations in rifampicine-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. Biotechnol J 1 (12):1447-1452
41. Park YK, Shin S, Ryu S, Cho SN, Koh WJ, Kwon OJ, Shim YS, Lew WJ, Bai GH (2005) Comparison of drug resistance genotypes between Beijing and non-Beijing family strains of Mycobacterium tuberculosis in Korea. J Microbiol Methods 63 (2):165-172 (Pubitemid 41444246)